Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine and Parent Management Training in Autism with ADHD Symptoms
NCT00844753Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Oct 2008
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Rochester. Started Oct 2008; status: completed.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00844753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844753.